insulin glp-1 glp 1 articles receptor agonists for individualized treatment of type 2 diabetes mellitus GLP-1 Medications Infographic Schematic of action of GLP-1

Because it has a long half-life of about five days, the drug stays active in your system throughout the entire week regardless of whether you inject it in morning, afternoon, or evening

Japan Demand for GLP-1 receptor agonists in Japan is projected to rise at 6.4% CAGR through 2036

Part 1: Big pharma eyes China at forefront of GLP-1 revolution Part 2: China biotechs rise to challenge Ozempic, Wegovy Part 3: Novo Nordisk seeks to repurpose GLP-1s, again, for the brain

Many patients find taste disturbances resolve spontaneously within weeks of starting Ozempic, so a period of watchful waiting with supportive measures may be appropriate before considering alternatives